PST0 Stock Chart & Stats
€6.35
-€0.05(-0.74%)
At close: 4:00 PM EDT
€6.35
-€0.05(-0.74%)
Day’s Range― - ―
52-Week Range€3.28 - €17.40
Previous CloseN/A
Volume0.00
Average Volume (3M)16.00
Market Cap
€85.09M
Enterprise Value€878.48M
Total Cash (Recent Filing)€87.80M
Total Debt (Recent Filing)€682.40M
Price to Earnings (P/E)―
Beta2.14
Next Earnings
Nov 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.84
Shares Outstanding13,641,866
10 Day Avg. Volume50
30 Day Avg. Volume16
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)-0.26
Price to Sales (P/S)0.05
P/FCF Ratio0.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Debt ReductionThe DBM Global divestiture provides substantial cash to retire debt and terminate credit facilities, directly improving capital structure flexibility. Lower obligations should reduce financing pressure and allow management to focus resources on the remaining life sciences and spectrum businesses over the next several quarters.
Cash GenerationStrong recent operating and free cash flow gives INNOVATE an internal source of liquidity for debt service, restructuring and investment. Although cash flow has been volatile historically, the current level materially improves the company’s ability to fund operations and support deleveraging without relying solely on external capital.
Improving OperationsRevenue growth combined with a substantial improvement in operating margin indicates better underlying execution and stronger earnings conversion. Continued operating improvement would strengthen cash generation and help offset financial costs, while providing a more durable base for the company’s post-divestiture portfolio.
Bears Say
Balance-Sheet RiskThe company retains a thin equity cushion relative to its asset base, leaving limited protection if operating performance weakens or asset values fall. High leverage can keep interest and refinancing demands elevated, constraining capital allocation even after the announced debt repayments are completed.
Continuing Net LossesImproved operating profitability has not yet translated into sustainable bottom-line earnings. Continued net losses can consume financial flexibility, limit internally funded investment and make debt reduction more dependent on asset sales or financing actions rather than recurring profitability from the operating portfolio.
Portfolio Revenue ShrinkageSelling DBM Global reduces leverage but also removes a major operating contributor from consolidated results. The remaining life sciences and other businesses must replace that scale over time, creating execution risk around revenue continuity, earnings diversification and the company’s ability to support fixed financial obligations.
INNOVATE Corp News
PST0 FAQ
What was INNOVATE Corp’s price range in the past 12 months?
INNOVATE Corp lowest stock price was €3.28 and its highest was €17.40 in the past 12 months.
What is INNOVATE Corp’s market cap?
INNOVATE Corp’s market cap is €85.09M.
When is INNOVATE Corp’s upcoming earnings report date?
INNOVATE Corp’s upcoming earnings report date is Nov 17, 2026 which is in 33 days.
How were INNOVATE Corp’s earnings last quarter?
INNOVATE Corp released its earnings results on Aug 06, 2026. The company reported €0.665 earnings per share for the quarter.
Is INNOVATE Corp overvalued?
According to Wall Street analysts INNOVATE Corp’s price is currently Overvalued.
Does INNOVATE Corp pay dividends?
INNOVATE Corp does not currently pay dividends.
What is INNOVATE Corp’s EPS estimate?
INNOVATE Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does INNOVATE Corp have?
INNOVATE Corp has 13,641,866 shares outstanding.
What happened to INNOVATE Corp’s price movement after its last earnings report?
INNOVATE Corp reported an EPS of €0.665 in its last earnings report. Following the earnings report the stock price went up 38.462%.
Which hedge fund is a major shareholder of INNOVATE Corp?
Currently, no hedge funds are holding shares in DE:PST0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
INNOVATE Corp Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
DE:PST0 Sentiment 100%
Sector Average 64%
Sector Average 64%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
36.90%
12-Months-Change
Fundamentals
Return on Equity
9.58%
Trailing 12-Months
Asset Growth
13.00%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
INNOVATE Corp
INNOVATE Corp. (VATE), a New York-based entity founded in 1994 and previously known as HC2 Holdings, Inc. until its name change in September 2021, manages a diverse range of subsidiaries operating within the infrastructure, life sciences, and spectrum sectors across the United States. Its extensive infrastructure division delivers services such as industrial construction, structural steel work, and facility maintenance. These capabilities are applied to a wide array of projects, including commercial structures like office complexes, hotels, casinos, convention centers, sports arenas, shopping malls, and hospitals, as well as significant industrial and civic infrastructure like dams, bridges, mines, metal processing plants, refineries, pulp and paper mills, and power generation facilities. INNOVATE also manufactures specialized components such as trusses, girders, water pipes, storage tanks, tunnel liners, pressure vessels, strainers, filters, separators, and other custom products. The company additionally offers integrated solutions encompassing digital engineering, modeling, detailing, construction, heavy equipment installation, and facility services, alongside expert steel and rebar detailing and BIM modeling and management. Furthermore, it supplies equipment critical to the oil, gas, petrochemical, and pipeline industries. Within the life sciences realm, INNOVATE focuses on the development of products designed to address early osteoarthritis of the knee, as well as aesthetic and medical technologies for skin care. Finally, its spectrum operations include the management of various over-the-air broadcasting stations and the operation of Azteca America, a Spanish-language broadcast network.
PST0 Company Deck
PST0 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call reflects a predominantly positive operational story driven by a strong Infrastructure / DBMG performance that delivered outsized revenue (up 33% consolidated) and adjusted EBITDA improvement. Significant regulatory and clinical milestones at MediBeacon and international growth at R2 are constructive. However, meaningful challenges remain in smaller but important areas: Life Sciences revenues fell sharply (-48.4%), R2 is seeking external capital, Spectrum experienced advertising weakness and cancellations, DBMG saw ~140 bps gross margin compression, and consolidated debt increased due to PIK interest. Overall, the positive momentum in the company’s largest revenue driver and improved overall profitability outweighs the segment‑level headwinds, but capital structure and segment weaknesses warrant continued attention.View all DE:PST0 earnings summariesTechnical Analysis
1 Day
3 Days
1 Week
1 Month
SUNation Energy
―
Energy Services of America
―
Shimmick Corporation
―
SKK Holdings Limited
―
―








